As of 2026-03-31, 济川药业's data on the DeepSeek platform in the 健康保健 category shows: The overall mention rate is 0.00%, below the industry average by 2.4 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 济川药业's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
济川药业's Mention Rate is 0.00%, lower than 0.6% of competitors
济川药业's First Mention is 0.00%, lower than 0.9% of competitors
济川药业's Preferred Rate is 0.00%, lower than 100.0% of competitors
济川药业's Positive Rate is 0.00%, lower than 8.9% of competitors
济川药业's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 北北京同仁堂 | 24.49% | 8.16% | 0% | 12.24% | 18.37% | View Details |
| 汤汤臣倍健 | 22.45% | 10.2% | 14.29% | 20.41% | 2.04% | View Details |
| SSwisse | 20.41% | 4.08% | 7.14% | 20.41% | 0% | View Details |
| NNature Made | 20.41% | 4.08% | 0% | 20.41% | 0% | View Details |
| 诺诺特兰德 | 14.29% | 4.08% | 0% | 10.2% | 4.08% | View Details |
| 同同仁堂 | 12.24% | 4.08% | 0% | 10.2% | 2.04% | View Details |
| 济济川药业 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
